External Innovation
Deerfield’s infrastructure can support the development of compelling assets on behalf of or in partnership with strategics and corporate partners.
The Deerfield team is able to acquire, transform, mature, and integrate development-stage and commercial assets prior to or in preparation for a corporate acquisition.
Our infrastructure includes access to in-building laboratory space with state-of-the-art equipment; partnerships with strategics, CROs, and consultants; and collaborations with academics and institutional research groups in the United States and elsewhere.
We're also capable of structuring creative, flexible financial and operational support for interested partners.
Alo Solutions
Deerfield partnered with Blue Cross Blue Shield of North Carolina to create Alo, a physician enablement platform enabling North Carolina physicians to manage the business of medicine.
Vanova Health
Deerfield worked with Blue Cross Blue Shield of New Jersey to build Vanova Health, which provides essential tools and services to support independent physician practices.
Meet our Healthcare Services team.
Neomorph
Deerfield and Dana-Farber Cancer Institute investigators launched Neomorph to advance the development of innovative new medicines against "undruggable" targets.
Nuvalent
Deerfield teamed up with Harvard professor and now-CEO James Porter to build Nuvalent, a company working to create precisely targeted therapies for patients with cancer.
Meet our Therapeutics team.
Deerfield Catalyst
Deerfield Catalyst is a medtech incubator at Cure committed to developing transformational solutions to improve patient outcomes and streamline care.
Cathworks
Deerfield worked with Medtronic to acquire and mature Cathworks prior to integration into Medtronic's core business.
Meet our MedTech team.
Deerfield has access to extensive in-building laboratory space, which includes complex equipment like cryo-EM, NMR, flow cytometry, automated screening robots, and high-throughput mass spectrometry.
.jpg)
